Related Posters
DNA Microarrays for Microbiological Diagnosis in Stem Cell Cultures
,
,
In stem cell cultures there is the possibility of infectious disease transmission to the recipients. Any microbial contamination of the donor`s biological products or introduced during the manufacturing process can potentially present a serious hazard to the recipients. The majority of potential contaminants are mycoplasma and other bacterias, yeasts and fungi. Moreover, viral and prion contamination of cell cultures and “feeder” cells is also a common risk.
Related news from our archive
Stem Cell Innovations to Supply PluriCells™ to Stanford University Researchers
Stem Cell Innovations PluriCells™ provide an alternative to ES cells.
International Accord Gives U.S. Firm Rights to Stem Cell Liver Cure
The focus of the agreement is to extend IIBM's Stem Cell Liver Regeneration procedure to the western world.
European Union Powers Ahead with €12 Million Funding for Human Embryonic Stem Cell Research Consortium
Stem Cell Sciences will participate in the European Commission approved "ESTOOLS" program, a human embryonic stem cell research initiative involving both academic and commercial researchers.
European Union Powers Ahead with Euro 12 Million Funding for Human Embryonic Stem Cell Research Consortium
Stem Cell Sciences will participate in the European Commission approved "ESTOOLS" program, a human embryonic stem cell research initiative involving both academic and commercial researchers.
Stem Cell Innovations to Supply PluriCells™ to Stanford University Researchers
Stem Cell Innovations PluriCells™ provide an alternative to ES cells.
International Accord Gives U.S. Firm Rights to Stem Cell Liver Cure
The focus of the agreement is to extend IIBM's Stem Cell Liver Regeneration procedure to the western world.
European Union Powers Ahead with €12 Million Funding for Human Embryonic Stem Cell Research Consortium
Stem Cell Sciences will participate in the European Commission approved "ESTOOLS" program, a human embryonic stem cell research initiative involving both academic and commercial researchers.
European Union Powers Ahead with Euro 12 Million Funding for Human Embryonic Stem Cell Research Consortium
Stem Cell Sciences will participate in the European Commission approved "ESTOOLS" program, a human embryonic stem cell research initiative involving both academic and commercial researchers.
StemCells, Inc. Grants License to Stem Cell Therapeutics
The agreement provides StemCells with access to SCT's intellectual property portfolio.
Stem Cell Innovations PluriCells™ Provide Alternative to the Presidential Veto
Stem Cell Innovations PluriCells™ provide an alternative to ES cells and are available for broad-based government funding.
Stem Cell Authority Offers Ethical Alternative to Alleviate Political Stem Cell Deadlock Between U.S. Congress and President
The ethical alternative offered by Stem Cell Authority Ltd. is the use of Wharton's Jelly matrix stem cells.
Stem Cell Innovations Cites Johns Hopkins Study as Growing Evidence of Potential for Stem Cell Treatment of Spinal Injuries
In the study researchers have engineered, completed, fully working motor neuron circuits in paralyzed adult animals.